Kineta, Inc./De

Ownership Transactions Reported by 21 Insiders

Symbol
KANT on OTC
Industry
Pharmaceutical Preparations
Location
7683 Se 27 Th Street, Suite 481, Mercer Island, WA

There are no Buy or Sell transactions made by insiders since 12/22/2023

Kineta, Inc./De executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Shawn Iadonato Director $3.08M Sep 4, 2024
Raymond J. Bartoszek Director $978K Sep 4, 2024
Marion R. Foote Director $644K Sep 4, 2024
Craig W. Philips President and Secretary $430K Apr 14, 2024
Paulash Mohsen Chief Business Officer $266K Feb 3, 2022
Ajay Verma EVP, Head of R&D $136K Dec 1, 2021
Thierry Guillaudeux Chief Scientific Officer $97.6K Apr 14, 2024
Pauline Kenny General Counsel & Secretary $83K Sep 20, 2023
Keith Baker Chief Financial Officer $76K Apr 14, 2024
Michael D. Wyzga Sr. VP & Chief Financial Officer $63K Dec 2, 2022
Devin W. Smith SVP and General Counsel $62.8K Dec 2, 2022
Marie Epstein Principal Accounting Officer $40K Dec 2, 2022
Richard Peters Director Sep 4, 2024
Scott J. Dylla Director Sep 4, 2024
David Arkowitz Director Sep 4, 2024
Kimberlee C. Drapkin Director Sep 4, 2024
Cecil B. Pickett Director Jun 2, 2021
Lynne Zydowsky Director Jun 2, 2021
Patricia L. Allen Director Jun 2, 2021
Richard A. Heyman Director Jun 2, 2021
Jeffery W. Kelly Director Jun 2, 2021

Recent Insider Transactions by Companies or Individuals for Kineta, Inc./De

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.